Clinical Trial Update: Phase I Trial of 5-Azacitidine Plus Gemcitabine in Patients With Advanced Pancreatic Cancer [Phase 1]

View source ↗

Summary

This document updates on a Phase I trial combining azacitidine and gemcitabine in patients with advanced pancreatic cancer, which has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: University of Oklahoma | Conditions: Pancreatic Cancer | Phase 1 | Status: TERMINATED